Shovman Ora, Levy Yair, Gilburd Boris, Shoenfeld Yehuda
Department of Medicine B, Sheba Medical Center, Tel Hashomer and Sackler Faculty of Medicine, Tel-Aviv University.
Immunol Res. 2002;25(3):271-85. doi: 10.1385/IR:25:3:271.
Inhibitors of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase or statins constitute the most powerful class of lipid lowering drugs, widely used in medical practice. During the past several years additional actions of statins unrelated to cholesterol reduction have been identified which includes antiinflammatory and immunomodulatory properties. Since atherosclerosis is a form of inflammation and the immune system play an important role in its pathogenesis, pleiotropic effect of statins may provide complementary explanation to their clinical benefit. This article reviews the data regarding the antiinflammatory and immunomodulatory properties of the statins that are available in the treatment of atherosclerosis and possibly may be applicable in other inflammatory diseases or conditions with the involvement of the immune system.
3-羟基-3-甲基戊二酰辅酶A(HMG-CoA)还原酶抑制剂或他汀类药物是最有效的一类降脂药物,在医学实践中广泛应用。在过去几年中,已发现他汀类药物有一些与降低胆固醇无关的其他作用,包括抗炎和免疫调节特性。由于动脉粥样硬化是一种炎症形式,且免疫系统在其发病机制中起重要作用,他汀类药物的多效性作用可能为它们的临床益处提供补充解释。本文综述了有关他汀类药物抗炎和免疫调节特性的数据,这些特性可用于治疗动脉粥样硬化,也可能适用于其他涉及免疫系统的炎症性疾病或病症。